Geode Capital Management
ORTX

Geode Capital Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Geode Capital Management’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,608
Closed -$9K – 4840
2022
Q4 		$9K Hold
2,608
– – ﹤0.01% 4852
2022
Q3 		$13K Hold
2,608
– – ﹤0.01% 4965
2022
Q2 		$15K Hold
2,608
– – ﹤0.01% 4962
2022
Q1 		$18K Buy
+2,608
New +$25.6K ﹤0.01% 4936
2021
Q3 		– Sell
-3,275
Closed -$143K – 4881
2021
Q2 		$143K Buy
3,275
+208
+7% +$11.6K ﹤0.01% 4463
2021
Q1 		$222K Buy
+3,067
New +$218K ﹤0.01% 4082
2020
Q4 		– Sell
-3,401
Closed -$139K – 4295
2020
Q3 		$139K Buy
3,401
+334
+11% +$17.3K ﹤0.01% 3822
2020
Q2 		$184K Buy
3,067
+1,079
+54% +$98.9K ﹤0.01% 3688
2020
Q1 		$149K Buy
+1,988
New +$229K ﹤0.01% 3638

Other funds holding ORTX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
KI
Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Geode Capital Management's ORTX Position: Q1 2023 in Review

Geode Capital Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2023, closing a stake of 2,608 shares — an estimated $9K sold.

Geode Capital Management first reported a position in ORTX in Q1 2020 and held it in 9 quarters. The position peaked at $222K in Q1 2021. 35 funds tracked by Wall St. Rank hold ORTX as of Q1 2023.

  • Geode Capital Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Geode Capital Management sold 2,608 Orchard Therapeutics plc American Depositary Shares shares in Q1 2023, an estimated $9K.
  • Geode Capital Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2020 and held it in 9 quarters.
  • Geode Capital Management's Orchard Therapeutics plc American Depositary Shares position peaked at $222K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2023.

Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.